Alnylam Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ALNY for the last quarter is 659.83 M USD, and it's 33.48% higher compared to the previous quarter. The net income of Q2 24 is -16.89 M USD.